Sanvira Biosciences Pvt. Ltd

Sanvira Biosciences Pvt Ltd (SBS), a key subsidiary of the US$ 440 million Sanvira Group (www.sanvira.com), specializes in the bioprocessing of microbial fermentation and the development of bioactive derivatives. Leveraging our expertise, we provide world-class proprietary strains of probiotics, functional postbiotics, specialty enzymes, and other bio-ingredients tailored for the pharmaceuticals, dietary supplements, sports nutrition, infant formula, food & beverage, and animal nutrition industries. Strategically located in Visakhapatnam (Vizag), India, SBS benefits from proximity to major logistical hubs, ensuring efficient operations and distribution. Our state-of-the-art fermentation facility, currently under development, spans over 180,000 sq. ft and meets stringent regulatory standards including NSF, FDA, EFSA, FSSC, and FAMIQs. This facility, compliant with cGMP guidelines, underscores our commitment to operational excellence and quality assurance. Going ahead, Phase II will introduce a world-class formulation facility, enhancing our capabilities in bioprocessing and enabling us to deliver innovative finished dosage formulations to global markets. Our Strengths: o Operations: Over 20 yrs of strategic management and precise process implementation in core manufacturing o R&D: Specializing in microbial and fermentation technology with a focus on regulatory compliance o Product Innovation: Development of proprietary probiotic strains, postbiotics, enzymes, and other bioactive derivatives o Management: Extensive experience in core manufacturing and a proven track record of global client collaboration o Technical Advisory Board: Provides invaluable insights into process engineering, quality systems, and regulatory compliance Backed by the financial strength and infrastructure of the Sanvira Group, Sanvira Biosciences (SBS) stands at the forefront of bioprocess technology, positioning itself as a leader in microbial fermentation and bioactive derivatives.